Cite
APA Citation
Kim, D., Kwak, Y., Kim, N. D., & Sim, T. (2016). antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations. Cancer biology & therapy, 17(1), 65–78. http://access.bl.uk/ark:/81055/vdc_100031754798.0x00005c